One person reportedly fell ill in September after receiving the Oxford corona vaccine. At that time, the trial of the vaccine was temporarily suspended, which has now been resumed.
London, October 26: The whole world now hopes for the Oxford corona vaccine. The trial of this vaccine is also underway in India. One person’s health deteriorated after the vaccine was given in September, and testing for the vaccine was temporarily suspended. Meanwhile, new information is coming out about the trial of this vaccine.
The vaccine was developed by Oxford University and AstraZeneca. The Serum Institute of India is also a partner in this vaccine. AstraZeneca has reported the effects of the vaccine. The vaccine develops immunity in people of both adult and young age, the company said.
The vaccine, developed by Oxford and Astrazenka, has developed corona-resistant antibodies and T-cells in adults. This is stated in the news of The Financial Times.
A spokeswoman for AstraZeneca told Reuters: “Immunogenicity response is good in adults and young people, and reactogenicity response is low in adults. Covid-19 can be more severe in seniors, so the findings are comforting. AZD1222 vaccine There will be concrete evidence.
Read this – Get ready! Oxford’s corona vaccine expected in November
Details of the research will soon be published in a clinical journal, according to the Financial Times. He did not name the publication. British Health Secretary Matt Hancock said: “Even though the vaccine is not ready yet, we are preparing for its delivery.
Meanwhile, the vaccine is expected to be available in November. Hospitals in London have been instructed to start preparations for the corona vaccine. Reuters quoted The Sun as saying. According to the report, the first batch of corona vaccine will be delivered to the hospitals soon.